Billings Clinic
Especially For:

Clinical Trials

Title   Lymphoma (C50904): Follicular Lymphoma Untreated
Description   A Phase II Study of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib, and Bendamustine in Patients wiht Untreated Follicular Lymphoma
IRB Number   CTSU C50904
Category   Lymphoma
Inclusion/Notes   No Prior Treatment
PS 0-2
Age 18 or older
No CNS Involvement with Lymphoma
Status   Open
Start Date   06/08/2012
Principal Investigator (PI)   Brock Whittenberger, MD
Physician Profile   Hematology/Oncology
Contact Name   Linda Allen, RN
Contact Email   tmontgomery@billingsclinic.org
Phone   (406) 435-7483
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.